Awardee OrganizationWAKE FOREST UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
Project Summary
Heart failure (HF) with preserved ejection fraction (HFpEF) is most common form of HF in the US and is
associated with high morbidity and mortality. HFpEF disproportionately affects women and non-Hispanic Black
persons. HFpEF is now understood as a heterogeneous syndrome intertwined with aging and multiple
comorbidities, and likely has multiple phenotypes. The pathophysiology remains incompletely understood and
few evidence-based treatments exist. This is the premise for HeartShare, a pivotal NHLBI initiative, whose
ultimate goals are to discover novel biological signals that will lead to actionable targets to inform future HFpEF
interventions.10 HeartShare is developing a Registry of 10,000 HF patients and matched comparators, and a
comprehensive 1000 participant Deep Phenotyping cohort. The Deep Phenotyping arm has to date recruited
262 participants from 7 sites. Of these, 80%, are White, and only 11% are African American, considerably
below the expected goal. There has developed a broad consensus among HeartShare stakeholders that
additional effort and support are needed to develop and implement strategies to help achieve diversity goals,
and specifically for a ‘Diversity Champion’ approach. Without the urgent, coordinated intervention in this
proposal to enhance inclusivity, participant diversity is likely to continue to be suboptimal, jeopardizing
HeartShare’s validity and generalizability. The Wake Forest-Atrium HeartShare Clinical Site has a diverse
investigator team, has consistently exceeded diversity enrollment targets in many clinical studies, and to date
leads overall Heart Share enrollment and has the highest percentage of female participants and the second
highest percentage of Black participants among the 7 sites. The overall goal of this proposal is to enhance
enrollment of under-represented groups across HeartShare sites by carrying out the following Aims: 1)
Completing a comprehensive assessment of resources and strategies for enrolling URM participants at each of
the clinical sites across HeartShare, as well as outcomes to date; 2) Utilizing the results of the comprehensive
assessment to develop optimal practices for enrollment of URM participants in HeartShare, test and refine
them at Wake Forest’s site, and then disseminate and help implement them across all HeartShare sites; 3)
Continuously monitor progress and dynamically adjust strategies as needed to help ensure optimal participant
diversity and inclusion across HeartShare. Our proposal is supported by: 1) An unexpected, compelling need
in a pivotal, ongoing NHLBI study; 2) Preliminary data indicating lack of a cohesive, robust, organized
approach to diversity and inclusion; 3) a diverse, multi-disciplinary leadership team consisting of a promising
minority female early career investigator combined with highly experienced senior investigators and staff, who
together have developed a strong track record for diverse participant enrollment in HeartShare and multiple
other trials; 4) enthusiastic support of the HeartShare Data Translational Center and Clinical Sites.
Public Health Relevance Statement
Narrative
HeartShare seeks to enroll persons with heart failure with preserved ejection fraction (HFpEF), a complex and
poorly understood disease, as well as control participants, into an observational study designed to clarify the
causes of HFpEF. Non White persons are more likely to have HFpEF but have been underrepresented in prior
research and in HeartShare itself thus far; after 1/4th of recruitment is completed, less than 20% are non-White
(goal is 40% non White enrollment). Thus we propose appointing a Diversity Champion to work closely with the
HeartShare study leaders to accomplish the following: comprehensively assess resources and strategies for
enrolling minority participants at each of the 7 clinical sites, use the results of the assessment to develop
optimal practices for diversifying enrollment tailored to each site’s population, share these practices with
HeartShare sites, and to continuously monitor progress and dynamically adjust strategies as needed to help
ensure optimal participant diversity and inclusion across HeartShare.
No Sub Projects information available for 3U01HL160272-04S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3U01HL160272-04S1
Patents
No Patents information available for 3U01HL160272-04S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3U01HL160272-04S1
Clinical Studies
No Clinical Studies information available for 3U01HL160272-04S1
News and More
Related News Releases
No news release information available for 3U01HL160272-04S1
History
No Historical information available for 3U01HL160272-04S1
Similar Projects
No Similar Projects information available for 3U01HL160272-04S1